Abstract
The catalytic asymmetric dihydroxylation (AD) discovered by Sharpless, a Nobel Prize winner in 2001, has rapidly become an invaluable synthetic tool in the possibility of converting prochiral olefins to chiral vicinal diols. After our long-running investigation of optimized methodology for the production of stereo-defined diols based on the AD reaction, an efficient and environmentally friendly approach for the synthesis of (S)-metoprolol via AD reaction was reported. The synthetic route proceeded in four-step reactions of nucleophilic substitution, AD reaction, cyclization, and nucleophilic ring opening. The key step, AD reaction, proceeded effectively in homogeneous catalysis by using a soluble polymer chiral ligand QN-AQN-OPEG-OMe, which can be easily separated from the reaction system and reused at least four times while maintaining its high catalytic activity and enantioselectivity. This protocol has been demonstrated to produce kilogram quantities of (S)-metoprolol on scale.
Keywords: Asymmetric dihydroxylation, asymmetric synthesis, polymer ligand, recoverable, (S)-metoprolol, biocatalysis, migraine, headaches, anxiety, beta-blocker
Letters in Organic Chemistry
Title:Asymmetric Synthesis of (S)-metoprolol via Sharpless Asymmetric Dihydroxylation Induced by A Recoverable Polymer Ligand QN-AQNOPEG- OMe
Volume: 9 Issue: 7
Author(s): Sikun Cheng, Xueying Liu, Pingan Wang, Xiaoye Li, Wei He and Shengyong Zhang
Affiliation:
Keywords: Asymmetric dihydroxylation, asymmetric synthesis, polymer ligand, recoverable, (S)-metoprolol, biocatalysis, migraine, headaches, anxiety, beta-blocker
Abstract: The catalytic asymmetric dihydroxylation (AD) discovered by Sharpless, a Nobel Prize winner in 2001, has rapidly become an invaluable synthetic tool in the possibility of converting prochiral olefins to chiral vicinal diols. After our long-running investigation of optimized methodology for the production of stereo-defined diols based on the AD reaction, an efficient and environmentally friendly approach for the synthesis of (S)-metoprolol via AD reaction was reported. The synthetic route proceeded in four-step reactions of nucleophilic substitution, AD reaction, cyclization, and nucleophilic ring opening. The key step, AD reaction, proceeded effectively in homogeneous catalysis by using a soluble polymer chiral ligand QN-AQN-OPEG-OMe, which can be easily separated from the reaction system and reused at least four times while maintaining its high catalytic activity and enantioselectivity. This protocol has been demonstrated to produce kilogram quantities of (S)-metoprolol on scale.
Export Options
About this article
Cite this article as:
Cheng Sikun, Liu Xueying, Wang Pingan, Li Xiaoye, He Wei and Zhang Shengyong, Asymmetric Synthesis of (S)-metoprolol via Sharpless Asymmetric Dihydroxylation Induced by A Recoverable Polymer Ligand QN-AQNOPEG- OMe, Letters in Organic Chemistry 2012; 9 (7) . https://dx.doi.org/10.2174/157017812802139645
DOI https://dx.doi.org/10.2174/157017812802139645 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gender Disparities on Access to Care and Coronary Disease Management
Current Pharmaceutical Design Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents
Current Drug Targets Contraindications for Anticoagulation in Older Patients with Atrial Fibrillation: A Narrative Review
Current Drug Safety Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension
Current Hypertension Reviews Blood Brain Barrier in Hypoxic-Ischemic Conditions
Current Neurovascular Research Selectivity Problems with Drugs Acting on Cardiac Na<sup>+</sup> and Ca<sup>2+</sup> Channels
Current Medicinal Chemistry Sympathetic Overactivity in Patients with Chronic Renal Failure - The Culprit of Increased Cardiovascular Mortality?
Current Hypertension Reviews Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews β-Adrenergic Over-Stimulation and Cardio-Myocyte Apoptosis: Two Receptors, One Organelle, Two Fates?
Current Drug Targets Suppression of Cancer Invasiveness by Dietary Compounds
Mini-Reviews in Medicinal Chemistry EarlyVascularAgeing and Hypertension -A New Model for Understanding Cardiovascular Risk
Current Hypertension Reviews Editorial (Hot Topic: Achieving Current Goals in Prevention and Treatment of Vascular Disease: An Update)
Current Pharmaceutical Design Is Type D Personality Here to Stay? Emerging Evidence Across Cardiovascular Disease Patient Groups
Current Cardiology Reviews Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology The 21st Century Form of Vitamin E - Tocotrienol
Current Pharmaceutical Design Comparison of Intra and Post-operative Sedation Efficacy of Dexmedetomidinemidazolam and Dexmedetomidine-propofol for Major Abdominal Surgery
Current Drug Metabolism Subject Index To Volume 12
Current Pharmaceutical Design Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis
Current Medicinal Chemistry Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
CNS & Neurological Disorders - Drug Targets Formulation and In Vitro Evaluation of Solid Lipid Microparticles of Candesartan Cilexetil Floating Tablets
Drug Delivery Letters